Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |